Skip to content
Biodatica
Start free

Baptist Health South Florida

Miami, Florida

OncologyPhase II
Compare Sign in to watch

What changed

Phase I trial registered: 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery

2mo agoTrial registeredMay 20, 2026Source filing (opens the source filing in a new tab)

Momentum

97no change

Momentum 97 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

1,843 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE1 registered

    Apr 11, 2024

    Brain Metastases, Brain Metastases, Adult, Brain Cancer · RECRUITING · sponsor: Baptist Health South Florida · 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery

    ClinicalTrials.gov · NCT06048094 (opens the source filing in a new tab)

  2. Trial

    PHASE2 registered

    Jan 10, 2023

    Brain Metastases, Brain Cancer · RECRUITING · sponsor: Baptist Health South Florida · Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis

    ClinicalTrials.gov · NCT05554302 (opens the source filing in a new tab)

  3. Trial

    PHASE2 registered

    Jun 1, 2022

    Meningioma · RECRUITING · sponsor: Baptist Health South Florida · Cabozantinib for Patients With Recurrent or Progressive Meningioma

    ClinicalTrials.gov · NCT05425004 (opens the source filing in a new tab)

  4. Trial

    PHASE1 registered

    Apr 4, 2022

    Brain Metastases, Adult, Brain Metastases, Brain Cancer · RECRUITING · sponsor: Baptist Health South Florida · Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery

    ClinicalTrials.gov · NCT04689048 (opens the source filing in a new tab)

  5. Trial

    Study registered

    Nov 30, 2021

    Neurocognitive Disorders · RECRUITING · sponsor: Baptist Health South Florida · Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

    ClinicalTrials.gov · NCT05504681 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources